E-LIB Suche - Ergebnisse für: Ott, Patrick A.

1

INDUCE-2: A Phase I/II, open-label, two-part study of felad..:

Hilton, John F. ; Ott, Patrick A. ; Hansen, Aaron R....
Cancer Immunology, Immunotherapy. 73 (2024) 3 - p. , 2024

Link: https://doi.org/10.1007/..

2

Randomized Placebo-Controlled, Biomarker-Stratified Phase I..:

Glitza, Isabella C. ; Seo, Yongwoo David ; Spencer, Christine N....
Cancer Discovery. , 2024

Link: https://doi.org/10.1158/..

3

Final results of urelumab, an anti-CD137 agonist monoclonal..:

Khushalani, Nikhil I ; Ott, Patrick A ; Ferris, Robert L...
Journal for ImmunoTherapy of Cancer. 12 (2024) 3 - p. e007364 , 2024

Link: https://doi.org/10.1136/..

4

Ziv-aflibercept plus pembrolizumab in patients with advance..:

Baginska, Joanna ; Nau, Allison ; Gomez Diaz, Ilana...
Cancer Immunology, Immunotherapy. 73 (2024) 1 - p. , 2024

Link: https://doi.org/10.1007/..

5

Clonal dynamics of alloreactive T cells in kidney allograft..:

Dunlap, Garrett S. ; DiToro, Daniel ; Henderson, Joel...
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

6

A phase I/II study of LY3022855 with BRAF/MEK inhibition in..:

Buchbinder, Elizabeth I. ; Giobbie-Hurder, Anita ; Haq, Rizwan.
Investigational New Drugs. 41 (2023) 4 - p. 551-555 , 2023

Link: https://doi.org/10.1007/..

7

Challenges in neoantigen-directed therapeutics:

Lybaert, Lien ; Lefever, Steve ; Fant, Bruno...
Cancer Cell. 41 (2023) 1 - p. 15-40 , 2023

Link: https://doi.org/10.1016/..

8

Precision cancer medicine: Concepts, current practice, and ..:

Edsjö, Anders ; Holmquist, Louise ; Geoerger, Birgit...
Journal of Internal Medicine. 294 (2023) 4 - p. 455-481 , 2023

Link: https://doi.org/10.1111/..

9

A phase I/II study of MCS110 with BRAF/MEK inhibition in pa..:

Buchbinder, Elizabeth I. ; Giobbie-Hurder, Anita ; Ott, Patrick A.
Investigational New Drugs. 41 (2023) 3 - p. 365-370 , 2023

Link: https://doi.org/10.1007/..

10

Topical imiquimod in combination with brachytherapy for unr..:

Yeh, Jennifer E. ; Wan, Marilyn T. ; Alloo, Allireza...
JAAD Case Reports. 31 (2023) - p. 62-65 , 2023

Link: https://doi.org/10.1016/..

11

Retrospective Review of Outcomes After Radiation Therapy fo..:

Mahmood, Umair ; Huynh, Mai Anh ; Killoran, Joseph H....
International Journal of Radiation Oncology*Biology*Physics. 114 (2022) 4 - p. 666-675 , 2022

Link: https://doi.org/10.1016/..

12

First-in-human study of an OX40 (ivuxolimab) and 4-1BB (uto..:

Hamid, Omid ; Chiappori, Alberto A ; Thompson, John A...
Journal for ImmunoTherapy of Cancer. 10 (2022) 10 - p. e005471 , 2022

Link: https://doi.org/10.1136/..

13

Efficacy and safety of pembrolizumab for patients with prev..:

Shapira-Frommer, Ronnie ; Mileshkin, Linda ; Manzyuk, Ludmila...
Gynecologic Oncology. 166 (2022) 2 - p. 211-218 , 2022

Link: https://doi.org/10.1016/..

14

Topical imiquimod and cryotherapy in combination with syste..:

Yeh, Jennifer E. ; Wan, Marilyn T. ; Alloo, Allireza...
JAAD Case Reports. 27 (2022) - p. 162-166 , 2022

Link: https://doi.org/10.1016/..

15

Landscape of helper and regulatory antitumour CD4+ T cells ..:

Oliveira, Giacomo ; Stromhaug, Kari ; Cieri, Nicoletta...
Nature. 605 (2022) 7910 - p. 532-538 , 2022

Link: https://doi.org/10.1038/..